MPX-007 je antagonist NMDA receptora.[3]

MPX-007
5-[[(3,4-difluorofenil)sulfonilamino]metil]-6-metil-N-[(2-metil-1,3-tiazol-5-il)metil]pirazin-2-karboksamid
Nazivi
IUPAC naziv
5-[[(3,4-difluorofenil)sulfonilamino]metil]-6-metil-N-[(2-metil-1,3-tiazol-5-il)metil]pirazin-2-karboksamid
Drugi nazivi
  • 1688685-29-1
  • CHEMBL4071767
Identifikacija
3D model (Jmol)
  • CC1=NC(=CN=C1CNS(=O)(=O)C2=CC(=C(C=C2)F)F)C(=O)NCC3=CN=C(S3)C
Svojstva
C18H17F2N5O3S2
Molarna masa 453,48 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

Reference

уреди
  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  уреди
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478.